{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:48:32Z","timestamp":1759366112779,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.nrl.2020.08.018","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T22:32:16Z","timestamp":1604615536000},"page":"504-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Espectro de neuromielitis \u00f3ptica: \u00bfseropositivo para la anticuaporina es una entidad diferente de los pacientes que son seronegativos? Una perspectiva de Colombia"],"prefix":"10.1016","volume":"38","author":[{"given":"P.A.","family":"Ortiz Salas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gaviria Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Cort\u00e9s Bernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Moreno Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.F.","family":"Roa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Rodr\u00edguez Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2020.08.018_bib0130","first-page":"1","article-title":"Epidemiology of neuromyelitis optica in Latin America","volume":"3","author":"Alvarenga","year":"2017","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"10.1016\/j.nrl.2020.08.018_bib0135","doi-asserted-by":"crossref","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: Clinical features, immunopathogenesis and treatment","author":"Jarius","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.nrl.2020.08.018_bib0140","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","article-title":"Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders","volume":"84","author":"Jacob","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrl.2020.08.018_bib0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2020.08.018_bib0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/cells8020090","article-title":"Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease","volume":"8","author":"Mader","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.nrl.2020.08.018_bib0155","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients","volume":"264","author":"Hamid","year":"2017","journal-title":"J Neurol."},{"key":"10.1016\/j.nrl.2020.08.018_bib0160","first-page":"311","article-title":"Comparison of neuromyelitis optica spectra according to AQP4 antibody serostatus in a Mexican referral centre","volume":"65","author":"Antonio-Luna","year":"2017","journal-title":"Rev Neurol."},{"key":"10.1016\/j.nrl.2020.08.018_bib0165","first-page":"55","article-title":"Comparison of clinical features between aquaporin-4 antibody seropositive and seronegative patients in neuromyelitis optica and neuromyelitis optica spectrum disorder","volume":"23","author":"Kunadison","year":"2018","journal-title":"Neurol Asia."},{"key":"10.1016\/j.nrl.2020.08.018_bib0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflammation."},{"issue":"1-2","key":"10.1016\/j.nrl.2020.08.018_bib0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2014.03.033","article-title":"Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: a comparison with seropositive cases","volume":"341","author":"Siritho","year":"2014","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrl.2020.08.018_bib0180","article-title":"Efficacy and safety of satralizumab monotherapy for relapse prevention in neuromyelitis optica spectrum disorder (NMOSD): results from SAkuraStar, a double-blind placebo-controlled Phase 3 clinical study","author":"Traboulsee","year":"2019","journal-title":"ECTRIMS Online Library"},{"key":"10.1016\/j.nrl.2020.08.018_bib0185","doi-asserted-by":"crossref","first-page":"190","DOI":"10.22379\/2422402296","article-title":"Espectro de neuromielitis \u00f3ptica en Colombia, primera caracterizaci\u00f3n cl\u00ednico imagenol\u00f3gica en tres centros de Bogot\u00e1","volume":"32","author":"Reyes","year":"2016","journal-title":"Acta Neurol Colomb."},{"key":"10.1016\/j.nrl.2020.08.018_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127757","article-title":"Central nervous system idiopathic inflammatory demyelinating disorders in South Americans: A descriptive, multicenter, cross-sectional study","volume":"10","author":"Papais-Alvarenga","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.nrl.2020.08.018_bib0195","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/174720","article-title":"Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis","author":"Etemadifar","year":"2015","journal-title":"Mult Scler Int."},{"key":"10.1016\/j.nrl.2020.08.018_bib0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2020.08.018_bib0205","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: A multicenter analysis","author":"Mealy","year":"2012","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrl.2020.08.018_bib0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2018.01.001","article-title":"Diagnosis and management of neuromyelitis optica spectrum disorders - An update","volume":"17","author":"Bruscolini","year":"2018","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.nrl.2020.08.018_bib0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island Malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor","year":"2018","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.nrl.2020.08.018_bib0220","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/rg.2018170141","article-title":"Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis","volume":"38","author":"Dutra","year":"2018","journal-title":"Radiographics."},{"key":"10.1016\/j.nrl.2020.08.018_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol."},{"key":"10.1016\/j.nrl.2020.08.018_bib0230","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: A review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult Scler J."},{"key":"10.1016\/j.nrl.2020.08.018_bib0235","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/1352458513507822","article-title":"Brainstem manifestations in neuromyelitis optica: A multicenter study of 258 patients","volume":"20","author":"Kremer","year":"2014","journal-title":"Mult Scler J."},{"key":"10.1016\/j.nrl.2020.08.018_bib0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2015.05.034","article-title":"Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review","volume":"355","author":"Pereira","year":"2015","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrl.2020.08.018_bib0245","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458513515085","article-title":"Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset","volume":"20","author":"Collongues","year":"2014","journal-title":"Mult Scler J."},{"key":"10.1016\/j.nrl.2020.08.018_bib0250","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/1352458516685416","article-title":"Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea","volume":"23","author":"Seok","year":"2017","journal-title":"Mult Scler J."}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485320302978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485320302978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:15:19Z","timestamp":1759324519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485320302978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0213485320302978"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2020.08.018","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Espectro de neuromielitis \u00f3ptica: \u00bfseropositivo para la anticuaporina es una entidad diferente de los pacientes que son seronegativos? Una perspectiva de Colombia","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2020.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}